Arcoxia (Organon / Merck) Etoricoxib Tablets – Selective COX-2 Anti-Inflammatory

### Description
Arcoxia is an advanced, prescription-strength nonsteroidal anti-inflammatory drug (NSAID) co-marketed and manufactured under the trusted standards of Organon and Merck. Featuring Etoricoxib as its active pharmaceutical ingredient, it acts as a highly selective inhibitor of the cyclooxygenase-2 (COX-2) enzyme. By selectively blocking pain and inflammation pathways while sparing protective COX-1 gastric functions, it delivers powerful relief from chronic joint stiffness, swelling, acute gout flares, and dental pain with minimized gastrointestinal disruption.

### Key Features & Benefits
* Selective COX-2 Action: Specifically targets inflammation and pain pathways while preserving standard gastric lining protection.
* 24-Hour Sustained Relief: Long-acting formulation designed to provide steady, all-day comfort with a single daily dose.
* Trusted Global Heritage: Produced under the stringent pharmaceutical quality standards of Organon and Merck.
* Rapid Bioavailability: Absorbs quickly to alleviate acute flare-ups and restore normal joint mobility efficiently.

### How to Use
1. Storage: Store at room temperature below 30°C in a dry place, away from direct sunlight, heat, and moisture. Keep securely out of reach of children.
2. Preparation: Verify blister pack integrity and select the precise milligram strength prescribed for your specific medical condition.
3. Administration: Take orally with a full glass of water. Can be taken with or without food, though absorption may be faster on an empty stomach. Do not exceed the recommended daily dose.
4. Disposal: Safely discard any expired medication or empty blister strips according to local pharmaceutical disposal guidelines.